To do this, clinical trials need to use consistent core outcomes. Therefore, HARMONY Alliance researchers are running several Delphi Surveys to compile Core Outcome Sets (COS) for specific blood cancers/Hematologic Malignancies.
All the Delphi Surveys have been completed for HARMONY and for HARMONY PLUS. Consensus Meetings took place in March, May and October 2022.
What are COS and why do we need help from patients, clinicians, regulators and drug developers?